Form4insider filings, from the source

SEC Form 4 · accession 0000919574-18-002738

FENNEC PHARMACEUTICALS INC. · FENC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 29, 2014
Accepted (ET)
Mar 29, 2018 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 29, 2015P6,000$1.76A2,003,057ISee Footnote
Common StockF3Dec 29, 2015P6,000$1.76A1,477,174D
Common StockF1,F2Dec 30, 2015P1,000$1.75A2,004,057ISee Footnote
Common StockF3Dec 30, 2015P1,000$1.75A1,478,174D
Common StockF1,F2Dec 31, 2015P9,000$1.77A2,013,057ISee Footnote
Common StockF3Dec 31, 2015P9,000$1.77A1,487,174D
Common StockF1,F2Dec 31, 2015P4,300$1.84A2,017,357ISee Footnote
Common StockF3Dec 31, 2015P4,300$1.84A1,491,474D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

(+) This is the fourth part of a Form 4 filing for the reporting persons. There are four parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.